Huge thanks to our funding sources!!

• April 2025: Thank you DOD for funding our Idea Development Award to identify new epigenetically driven therapeutic vulnerabilities in metastatic castration resistant prostate cancer.
• February 2024: Thank you Mike Slive Foundation for funding our project on epigenetic therapies for bone metastatic castrate-resistant prostate cancer.
• February 2024: Congratulations Houssein on your DOD Prostate Cancer Research Program Early Investigator Research Award.
• From the get-go: Icahn School of Medicine at Mount Sinai, National Cancer Institute (K22 Career Development Award) and Prostate Cancer Foundation (Young Investigator Award).